A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
NCT ID: NCT01782482
Last Updated: 2014-05-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
574 participants
INTERVENTIONAL
2013-02-28
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
NCT02175199
A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS
NCT01635933
A Comparison of Silicone Hydrogel Contact Lenses: AIR OPTIX® COLORS Versus AIR OPTIX® AQUA
NCT01635920
Evaluation of the Performance of AIR OPTIX® COLORS
NCT01338402
Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS
NCT01398787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AIR OPTIX® COLORS
Lotrafilcon B contact lens with color worn on a daily wear basis for 7 days. Lenses were worn bilaterally for a minimum of 5 days per week, 8 hours per day.
Lotrafilcon B contact lens with color
Silicone hydrogel contact lens with color
FRESHLOOK® COLORBLENDS
Phemfilcon A contact lens with color worn on a daily wear basis for 7 days. Lenses were worn bilaterally for a minimum of 5 days per week, 8 hours per day.
Phemfilcon A contact lens with color
Hydrogel contact lens with color
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B contact lens with color
Silicone hydrogel contact lens with color
Phemfilcon A contact lens with color
Hydrogel contact lens with color
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to achieve best corrected visual acuity (BCVA) of 20/25 (Snellen) or better in each eye at distance.
* Manifest cylinder less than or equal to 0.75 diopter in each eye.
* Wear contact lenses within protocol-defined specifications.
* Require spherical contact lenses within the available range of powers.
Exclusion Criteria
* Any systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
* Moderate or severe ocular findings upon examination.
* Any use of systemic or ocular medications that could contraindicate contact lens wear, including use of topical ocular medications requiring instillation during contact lens wear, except for approved lubricating drops.
* Habitual lenses worn in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment.
* Previous corneal or refractive surgery or irregular cornea.
* Eye injury or surgery within the last 6 months (excluding placement of punctal plugs).
* Monovision and monocular subjects (only one eye with functional vision) or subjects fit with only one lens.
* History of intolerance or hypersensitivity to any component of the test articles.
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon Holden Thomas, O.D.
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-12-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.